Free Trial

This company has been marked as potentially delisted and may not be actively trading.

CAMP4 Therapeutics (CAMP) Earnings Date, Estimates & Call Transcripts

CAMP4 Therapeutics logo

CAMP4 Therapeutics Earnings Summary

CAMP4 Therapeutics posted Q1 2025 earnings on May 13, 2025, reporting an EPS of -$0.62, which topped the consensus estimate of -$0.70 by $0.08. Quarterly revenue was reported to be $0.86 million, above the consensus estimate of $0.10 million. With a trailing EPS of $0.00, CAMP4 Therapeutics' earnings are expected to grow next year, from ($4.99) to ($2.89) per share.

Latest Q1
Earnings Date
May. 13Estimated
Consensus EPS
(May. 13)
-$0.70
Actual EPS
(May. 13)
-$0.62 Beat By $0.08
Actual Revenue
(May. 13)
$0.86M
Get CAMP4 Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on CAMP4 Therapeutics and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

CAMP Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CAMP Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

CAMP4 Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20252-$0.69$0.05-$0.32
Q2 20254-$0.68$0.06-$0.49
Q3 20254-$0.69$0.04-$0.50
Q4 20253-$0.72-$0.31-$0.51
FY 2025 13 -$2.78 -$0.16 -$1.82
Q1 20261-$0.45-$0.45-$0.45
Q2 20261-$0.48-$0.48-$0.48
Q3 20261-$0.50-$0.50-$0.50
Q4 20261-$0.54-$0.54-$0.54

CAMP4 Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/13/2025Q1 2025-$0.70-$0.62+$0.08-$0.62$0.10M$0.86M
11/21/2024Q3 2024--$24.19--$24.19--
1/9/2024Q3 2024-$0.15-$0.20 -$0.05$1.87$51.80M$53.63M
10/5/2023Q2 2024-$0.92-$1.15 -$0.23$0.01$69.35M$61.71M

CAMP4 Therapeutics Earnings - Frequently Asked Questions

CAMP4 Therapeutics (NASDAQ:CAMP) last announced its quarterly earning data on Tuesday, May 13, 2025. Learn more on CAMP's earnings history.

In the previous quarter, CAMP4 Therapeutics (NASDAQ:CAMP) reported ($0.62) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.70) by $0.08. Learn more on analysts' earnings estimate vs. CAMP's actual earnings.

CAMP4 Therapeutics (NASDAQ:CAMP) has a recorded annual revenue of $650,000.00.

CAMP4 Therapeutics (NASDAQ:CAMP) has a recorded net income of -$51.79 million. CAMP has generated $0.00 earnings per share over the last four quarters.

CAMP4 Therapeutics' earnings are expected to grow from ($4.99) per share to ($2.89) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:CAMP) was last updated on 7/15/2025 by MarketBeat.com Staff
From Our Partners